Skip to main content
Clinical Trials/NCT01650363
NCT01650363
Unknown
Phase 3

Effect of Complementary and Alternative Medical Methods on the Post Operative Recovery Following Cardio-thoracic Surgery- a Pragmatic, Randomized,Single Blinded, Placebo Controlled Study

Shaare Zedek Medical Center1 site in 1 country100 target enrollmentOctober 2012

Overview

Phase
Phase 3
Intervention
Acupuncture, homeopathy, osteopathy- and reflexology
Conditions
Patients Undergoing Open Heart Surgery
Sponsor
Shaare Zedek Medical Center
Enrollment
100
Locations
1
Primary Endpoint
Improvement of Quality of Recovery questionnaire-40 (QoR-40)
Last Updated
13 years ago

Overview

Brief Summary

This is a randomized controlled clinical trial in which the combination of 4 different CAM modalities (Complementary & Alternative Medicine) will be applied during the postoperative period to patients undergoing open heart- or lung surgery and expected to be hospitalized for more than 5 days.

Elective and Urgent surgical patients will be randomly assigned to a treatment - and to a control group. The treatment group will be treated with a combination of 4 different CAM modalities (Homeopathy, Osteopathy, and Acupuncture & Reflexology) . The control group will be treated with Homeopathic placebo medication.

The main Outcome measurement in the study will be the Quality of recovery 40 questionnaire (QoR- 40) that will be filled out on postoperative days: 3, 5, and 7 respectively. Secondary outcome measurements will be Blood &Saliva Cortisol levels, DHES levels in the blood as surrogates of stress, IL-2 levels as measures of the immune system. Further parameters to be measured include: LOS (length of stay), Level of Pain, mobility, level of satisfaction, GI symptoms (nausea, first bowel movement), post-operative complications& side effects.

All patients participating in the trial will sign an informed consent form . The trial is expected to be conducted over a period of 12 months. Prior to the trial a pilot study will be conducted on a group of 30 patients in order to determine the needed sample size for the trial.

Registry
clinicaltrials.gov
Start Date
October 2012
End Date
October 2013
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Menachem Oberbaum

MD

Shaare Zedek Medical Center

Eligibility Criteria

Inclusion Criteria

  • Over 18 years of age
  • Patients planned to undergo a surgical procedure which will require an estimated hospitalisation of at least 5 days
  • Patients speaking Hebrew or English
  • Informed Consent signature

Exclusion Criteria

  • patients unable to comply with the study protocol
  • Participation in another clinical trial
  • Thrombocytopenia (\< 15.000 for acupuncture treatment

Arms & Interventions

Acupuncture, homeopathy, osteopathy and reflexology

patients will receive combinations of acupuncture, homeopathy, osteopathy and reflexology

Intervention: Acupuncture, homeopathy, osteopathy- and reflexology

homeopathic placebo medication

Intervention: Homeopathic placebo medication

Outcomes

Primary Outcomes

Improvement of Quality of Recovery questionnaire-40 (QoR-40)

Time Frame: days 3,5 and 7

Quality of Recovery questionnaire is a tool which is used primarily to assess the patient's recovery and state of health following surgery.

Secondary Outcomes

  • Analgesia Protocol(daily intake of anlagesic medications will be evaluated each evening throughout the study period (mean expected: 4 weeks))
  • Side-effects(every day; to be evaluated each evening throughout the study period (mean expected: 4 weeks))
  • Length of Stay(patients will be followed for the duration of the hospital stay, an expected average of 4 weeks)
  • First postoperative passage of flatus and first bowel movement.(the time to the first passage of flatus and bowel movements, an expected average of 3 days)
  • GI Symptoms(patients will be evaluated for GI symptoms until discharge (expected average 4 weeks))
  • Food intake(participants will be evaluated for the ingestion of the first solid meal (average: 4 days))
  • Patient Satisfaction(at discharge from hospital; expected mean: 4 weeks)
  • Immune System Function(2nd and 4th day after treatment initiation)
  • Ambulation(each day participants will be evaluated for ambulation (expected mean: 1 week))
  • Stress levels(Study entry, 2nd and 3rd day following the treatment initiation.)
  • Pain level estimation(first 3 days and day 6)
  • Hospitalization costs(At hospital discharge (mean expected: 4 weeks))
  • Postoperative complications(Every day, to be evaluated each evening throughout the hospital stay (mean expected: 4 weeks))
  • Fatigue(Daily at 3rd, 4th and 5th post operative days 3,4 and 5)

Study Sites (1)

Loading locations...

Similar Trials